Overview
Nesiritide is a medication used to treat acutely decompensated congestive heart failure with dyspnea at rest or with minimal exertion (such as talk, eating or bathing). Nesiritide is a 32 amino acid recombinant human B-type natriuretic peptide.
Background
Nesiritide is a medication used to treat acutely decompensated congestive heart failure with dyspnea at rest or with minimal exertion (such as talk, eating or bathing). Nesiritide is a 32 amino acid recombinant human B-type natriuretic peptide.
Indication
适用于急性代偿性心力衰竭、慢性失代偿性心力衰竭、心肌梗死、心脏导管手术等。由于静脉使用起效快，更适用于急性心力衰竭。
Associated Conditions
- Acute Decompensated Heart Failure (ADHF)
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2020/07/02 | N/A | UNKNOWN | Shanghai Zhongshan Hospital | ||
2019/11/08 | Phase 4 | UNKNOWN | |||
2019/07/26 | Phase 4 | Recruiting | |||
2018/11/13 | Phase 4 | Terminated | |||
2017/07/02 | Not Applicable | UNKNOWN | China National Center for Cardiovascular Diseases | ||
2016/04/19 | Phase 4 | Completed | LI ZHAO | ||
2015/12/30 | Early Phase 1 | Withdrawn | |||
2015/11/20 | Phase 1 | Recruiting | Oslo University Hospital | ||
2014/10/20 | Not Applicable | Withdrawn | |||
2013/11/07 | Phase 1 | Completed | AdventHealth Translational Research Institute |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Recombinant Human Brain Natriuretic Peptide for Injection | 国药准字S20250019 | 生物制品 | 注射剂 | 4/30/2025 | |
| Recombinant Human Brain Natriuretic Peptide for Injection | 国药准字S20050033 | 生物制品 | 注射剂 | 7/13/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||